GET THE APP

Free Regulatory Affairs Journals | Open Access Journals

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Submit Manuscript

Free Regulatory Affairs Journals

The mission of Pharmaceutical Regulatory Affairs uses provides a forum for publishing new findings on Regulatory Affairs and its related fields. Currently, our primary research objective is to encourage and assist the development of better and faster measures of research activity. In cases where we believe we can contribute directly, as opposed to highlighting the work of others, we are producing our own measures of publishing activity. Our work is mainly of interest to investors, organizations, and research individuals in the Regulatory Affairs and related fields. Pharmaceutical Regulatory Affairs Open Access is a journal dedicated to producing analysis, insight, and data relating to questions of importance in understanding the Regulatory Affairs. Pharmaceutical Regulatory Affairs journal from OMICS Group is an open-access journal named Pharmaceutical Regulatory Affairs Open Access Journal which strives to release issues quarterly and is adamant to publish new findings related to the field of Regulatory Affairs.

High Impact List of Articles

Conference Proceedings

The fetal safety of enoxaparin use during pregnancy
Amalia Levy
Scientific Tracks Abstracts: Journal of Formulation Science & Bioavailability
The fetal safety of enoxaparin use during pregnancy
Amalia Levy
Scientific Tracks Abstracts: Journal of Formulation Science & Bioavailability
Getting the NHS ready for the biosimilar boom: Shifting attitudes, acceptance and appetites
Theo Christie
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Getting the NHS ready for the biosimilar boom: Shifting attitudes, acceptance and appetites
Theo Christie
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Docking study of 2-aroyl-[1]benzopyrano[4,3-c]pyrazol-4(1H)-one derivatives and related hydrazide-hydrazones and their antimycobacterial activity
Valentin R. Karabelyov, Violina T. Angelova, Tania Pencheva, Yulian Voynikov, Violeta Valcheva, Nikolay Vassilev, Rositsa Mihaylova, Georgi Momekov and Boris Shivachev
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Docking study of 2-aroyl-[1]benzopyrano[4,3-c]pyrazol-4(1H)-one derivatives and related hydrazide-hydrazones and their antimycobacterial activity
Valentin R. Karabelyov, Violina T. Angelova, Tania Pencheva, Yulian Voynikov, Violeta Valcheva, Nikolay Vassilev, Rositsa Mihaylova, Georgi Momekov and Boris Shivachev
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Expression of antimicrobial peptide Hcap18/LL-37 following non-viral delivery of plasmid DNA encoded by CAMP gene in human fibroblasts and keratinocytes
Maria P, Natalia B and Luz R
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Expression of antimicrobial peptide Hcap18/LL-37 following non-viral delivery of plasmid DNA encoded by CAMP gene in human fibroblasts and keratinocytes
Maria P, Natalia B and Luz R
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Strategy for successful regulatory inspections in a phase I human pharmacology unit
Sudheendra Kulkarni
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Strategy for successful regulatory inspections in a phase I human pharmacology unit
Sudheendra Kulkarni
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine

Relevant Topics in Pharmaceutical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

Related Links

Open Access Journals